Showing results (221-230 of 523) with videos related to
Sort By:
Pageof 53
Wiener Klinische Wochenschrift|January 1, 1993
Coffee, lipoproteins and cardiovascular diseaseC Pirich, J O'Grady, H SinzingerEuropean Journal of Nuclear Medicine|September 2, 1998
Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringesR Bartosch, S Granegger, H SinzingerBritish Journal of Experimental Pathology|February 1, 1979
Prostacyclin activity in rat kidney stimulated by angiotensin IIK Silberbauer, H Sinzinger, M WinterZeitschrift Fur Kardiologie|January 1, 1993
The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activatorK Huber, R Beckmann, F Rauscha, et al.Wiener Medizinische Wochenschrift (1946)|October 31, 1981
[Optimized sequential pacing of atrium and ventricle (author's transl]P Fitscha, H Kassal, A Laczkovics, et al.Gerontology|January 1, 1982
Influence of smoking and age on pharmacokinetics of beta-receptor blockersG Hitzenberger, P Fitscha, T Beveridge, et al.Prostaglandins & Other Lipid Mediators|July 14, 1998
Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins?G Sobal, J E Menzel, H SinzingerBiochemical Pharmacology|February 15, 2001
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycationG Sobal, E J Menzel, H SinzingerWiener Klinische Wochenschrift|January 1, 1996
Imaging of atherosclerosis (Part II)H Kritz, S R Underwood, H SinzingerWiener Klinische Wochenschrift|January 1, 1996
Imaging of atherosclerosis (Part I)H Kritz, S R Underwood, H SinzingerPageof 53